A detailed history of Community Bank, N.A. transactions in Cel Sci Corp stock. As of the latest transaction made, Community Bank, N.A. holds 500 shares of CVM stock, worth $200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$200
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.17 - $2.86 $585 - $1,430
500 New
500 $0
Q1 2021

May 04, 2021

SELL
$12.0 - $27.64 $12,000 - $27,640
-1,000 Reduced 66.67%
500 $8,000
Q3 2020

Nov 03, 2020

SELL
$11.69 - $14.54 $40,915 - $50,890
-3,500 Reduced 70.0%
1,500 $19,000
Q4 2019

Feb 05, 2020

BUY
$6.71 - $9.55 $20,130 - $28,650
3,000 Added 150.0%
5,000 $46,000
Q2 2019

Jul 26, 2019

BUY
$3.77 - $8.67 $7,540 - $17,340
2,000 New
2,000 $17,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $17.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Community Bank, N.A. Portfolio

Follow Community Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.